The PD-L1 pathway involves expression of PD-1 on activated T cells (both CD8+ and CD4+), and PD-L1 which is expressed on cancer cells as well as inflammatory cells of the tumor microenvironment including macrophages. This evidence concerns the gene CD274 and cancer.